M, H., S, M., F, S., B, V., M, Z., KM, K., & DL, H. (2022). Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 30(9), 7355. https://doi.org/10.1007/s00520-022-07118-y
Chicago Style (17th ed.) CitationM, Hwang, Medley S, Shakeel F, Vanderwerff B, Zawistowski M, Kidwell KM, and Hertz DL. "Lack of Association of CYP2B6 Pharmacogenetics with Cyclophosphamide Toxicity in Patients with Cancer." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 30, no. 9 (2022): 7355. https://doi.org/10.1007/s00520-022-07118-y.
MLA (9th ed.) CitationM, Hwang, et al. "Lack of Association of CYP2B6 Pharmacogenetics with Cyclophosphamide Toxicity in Patients with Cancer." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 30, no. 9, 2022, p. 7355, https://doi.org/10.1007/s00520-022-07118-y.